RECRUITING

HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The Health Advocate for Liver Transplant (HEAL-Tx) Transition of Care Pilot is a nonrandomized, open-label intervention pilot of a health advocate intervention aimed to assess feasibility and acceptability of integrating a Health Advocate onto the transplant team to help adolescents transition their care to adult transplant teams. Across studies, health advocate roles vary, and can include coordinating medical care treatment, facilitating financial assistance (e.g., taxi vouchers), and connecting patients to community resources, which can improve self-management, mitigate social risks, and lead to better communication between the healthcare system and the family. In this pilot, the investigators will adapt this intervention for adolescent/young adult liver transplant patients and measure acceptability and feasibility according to RE-AIM.

Official Title

HEalth Advocate for Liver Transplantation: Improving Transition of Care for Adolescent Liver Transplant Recipients

Quick Facts

Study Start:2024-03-03
Study Completion:2026-06-30
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06386198

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:18 Years to 25 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT
Inclusion CriteriaExclusion Criteria
  1. 1. Patient has received a liver transplant \>1 year ago
  2. 2. Study team has screened patient and discussed with the primary transplant practitioner that patient may benefit from the Health Advocate program.
  3. 3. Patient has an unmet social risk (e.g., food insecurity) or MLVI \>/= 2.0.
  4. 4. Patient will be transferred to adult transplant team in \<6 months.
  5. 5. Patient can read and write English or Spanish
  6. 6. Patient is between 18-25 years old and can provide informed consent.
  7. 7. Patient has a working phone and smart device capable of video and/or audio virtual visits via Zoom.
  1. * Patient has significant cognitive impairment.
  2. * Does not meet age criteria
  3. * Patient is a ward of the state.
  4. * Non-English, non-Spanish speakers.
  5. * Non-US residents.

Contacts and Locations

Study Contact

Sharad Wadhwani, MD, MPH
CONTACT
510-428-3058
sharad.wadhwani@ucsf.edu

Principal Investigator

Sharad Wadhwani, MD, MPH
PRINCIPAL_INVESTIGATOR
University of California, San Francisco

Study Locations (Sites)

University of California San Francisco
San Francisco, California, 94158
United States
Children's Healthcare of Atlanta
Atlanta, Georgia, 30345
United States

Collaborators and Investigators

Sponsor: University of California, San Francisco

  • Sharad Wadhwani, MD, MPH, PRINCIPAL_INVESTIGATOR, University of California, San Francisco

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-03-03
Study Completion Date2026-06-30

Study Record Updates

Study Start Date2024-03-03
Study Completion Date2026-06-30

Terms related to this study

Keywords Provided by Researchers

  • Health Advocate
  • Patient Navigator

Additional Relevant MeSH Terms

  • Liver Transplant; Complications
  • Pediatric ALL